Opaleye Management Inc. Uni Qure N.V. Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $9.73 Million - $12.9 Million	-270,400 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $2.72 Million - $4.09 Million	60,400 Added 28.76%	270,400 $8.55 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $185,650 - $373,100	5,000 Added 2.44%	210,000 $15 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $5.61 Million - $14 Million	205,000 New	205,000 $12.2 Million
Q1 2018 May 14, 2018	SELL	$17.1 - $26.61 $1.55 Million - $2.42 Million	-90,801 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$9.47 - $19.59 $859,885 - $1.78 Million	90,801	90,801 $1.78 Million

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $290M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.